Skip to main content
Top
Published in: Langenbeck's Archives of Surgery 7/2016

01-11-2016 | ORIGINAL ARTICLE

The CaPTHUS score as predictor of multiglandular primary hyperparathyroidism in a European population

Authors: M. Mogollón-González, P. Notario-Fernández, M. Dominguez-Bastante, A. Molina-Raya, M. Serradilla-Martín, N. Muñoz-Pérez, J. I. Arcelus-Martínez, J. Villar-del-Moral, J. A. Jiménez-Ríos

Published in: Langenbeck's Archives of Surgery | Issue 7/2016

Login to get access

Abstract

Purpose

Focused parathyroidectomy has been proven to be a safe technique for the treatment of single-gland primary hyperparathyroidism (PHPT). The CaPTHUS scoring model has been reported to be an accurate preoperative diagnostic tool for distinguishing single-gland (SGD) from multiglandular disease (MGD), including preoperative serum calcium and PTH values plus ultrasound and Sestamibi scanning. The purpose of the present study was to validate the CaPTHUS model for the population in southern Europe, since the North American and the European populations show different clinicopathological profiles in PHPT.

Methods

This is a retrospective review of a prospectively maintained database of patients diagnosed with PHPT who underwent surgical treatment in a single referral center. Differences between SGD and MGD groups were analyzed using chi-square and Fisher’s exact tests for categorical variables and Student’s t test for continuous variables. Overall diagnostic accuracy of the scoring model was assessed by the area under the receiver operating characteristic (ROC) curve (AUC). A p < 0.05 level was accepted as significant.

Results

From January 2001 to November 2014, 241 patients were included in the study, of whom 92.1 % had SGD and 71.8 % had a CaPTHUS score ≥3. SGD was distinguished from MGD (p < 0.001) using the dichotomous scoring model based on an AUC value of 0.762. Scores ≥3 had a sensitivity of 76.5 % and a positive predictive value of 96 % for SGD.

Conclusions

Despite good test performance, a CaPTHUS score ≥3 does not discard MGD definitely. Intraoperative adjuncts are still needed to further reduce the risk of missing MGD during selective parathyroidectomy.
Literature
1.
2.
go back to reference Sackett WR, Barraclough B, Reeve TS, Delbridge LW (2002) Worldwide trends in the surgical treatment of primary hyperparathyroidism in the era of minimally invasive parathyroidectomy. Arch Surg 137:1055–1059CrossRefPubMed Sackett WR, Barraclough B, Reeve TS, Delbridge LW (2002) Worldwide trends in the surgical treatment of primary hyperparathyroidism in the era of minimally invasive parathyroidectomy. Arch Surg 137:1055–1059CrossRefPubMed
3.
go back to reference Adami S, Marcocci C, Gatti D (2002) Epidemiology of primary hyperparathyroidism in Europe. J Bone Miner Res 17:18–23 Adami S, Marcocci C, Gatti D (2002) Epidemiology of primary hyperparathyroidism in Europe. J Bone Miner Res 17:18–23
11.
go back to reference Haciyanli M, Lal G, Morita E, Duh QY, Kebebew E, Clark OH (2003) Accuracy of preoperative localization studies and intraoperative parathyroid hormone assay in patients with primary hyperparathyroidism and double adenoma. J Am Coll Surg 197:739–746CrossRefPubMed Haciyanli M, Lal G, Morita E, Duh QY, Kebebew E, Clark OH (2003) Accuracy of preoperative localization studies and intraoperative parathyroid hormone assay in patients with primary hyperparathyroidism and double adenoma. J Am Coll Surg 197:739–746CrossRefPubMed
12.
go back to reference Mazeh H, Chen H, Leverson G, Sippel RS (2013) Creation of a “Wisconsin index” nomogram to predict the likelihood of additional hyperfunctioning parathyroid glands during parathyroidectomy. Ann Surg 257(1):138–141. doi:10.1097/SLA.0b013e31825ffbe CrossRefPubMed Mazeh H, Chen H, Leverson G, Sippel RS (2013) Creation of a “Wisconsin index” nomogram to predict the likelihood of additional hyperfunctioning parathyroid glands during parathyroidectomy. Ann Surg 257(1):138–141. doi:10.​1097/​SLA.​0b013e31825ffbe CrossRefPubMed
13.
go back to reference Uldesman R, Donovan P, Shaw C (2014) Cure predictability during parathyroidectomy. World J Surg 38:525–533CrossRef Uldesman R, Donovan P, Shaw C (2014) Cure predictability during parathyroidectomy. World J Surg 38:525–533CrossRef
15.
16.
go back to reference Sepahdari AR, Bahl M, Harari A, Kim HJ, Yeh MW, Hoang JK (2015) Predictors of Multigland Disease In Primary Hyperparathyroidism: A Scoring System with 4D-CT imaging and biochemical markers. AJNR Am J Neuroradiol 36(5):987–992. doi:10.3174/ajnr.A4213 CrossRefPubMed Sepahdari AR, Bahl M, Harari A, Kim HJ, Yeh MW, Hoang JK (2015) Predictors of Multigland Disease In Primary Hyperparathyroidism: A Scoring System with 4D-CT imaging and biochemical markers. AJNR Am J Neuroradiol 36(5):987–992. doi:10.​3174/​ajnr.​A4213 CrossRefPubMed
17.
go back to reference Tublin ME, Pryma DA, Yim JH, Ogilvie JB, Mountz JM, Bencherif B et al (2009) Localization of parathyroid adenomas by sonography and technetium Tc 99m sestamibi single-photon emission computed tomography before minimally invasive parathyroidectomy: are both studies really needed? J Ultrasound Med 28(2):183–190PubMed Tublin ME, Pryma DA, Yim JH, Ogilvie JB, Mountz JM, Bencherif B et al (2009) Localization of parathyroid adenomas by sonography and technetium Tc 99m sestamibi single-photon emission computed tomography before minimally invasive parathyroidectomy: are both studies really needed? J Ultrasound Med 28(2):183–190PubMed
19.
go back to reference Brandi ML, Gagel RF, Angeli A et al (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Meta 86:5658–5671CrossRef Brandi ML, Gagel RF, Angeli A et al (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Meta 86:5658–5671CrossRef
20.
go back to reference AACE/AAES Task Force on Primary Hyperparathyroidism (2005) The American Association of Clinical Endocrinologists and the American Association of Endocrine Surgeons position statement on the diagnosis and management of primary hyperparathyroidism. Endocr Pract 11:49–54CrossRef AACE/AAES Task Force on Primary Hyperparathyroidism (2005) The American Association of Clinical Endocrinologists and the American Association of Endocrine Surgeons position statement on the diagnosis and management of primary hyperparathyroidism. Endocr Pract 11:49–54CrossRef
Metadata
Title
The CaPTHUS score as predictor of multiglandular primary hyperparathyroidism in a European population
Authors
M. Mogollón-González
P. Notario-Fernández
M. Dominguez-Bastante
A. Molina-Raya
M. Serradilla-Martín
N. Muñoz-Pérez
J. I. Arcelus-Martínez
J. Villar-del-Moral
J. A. Jiménez-Ríos
Publication date
01-11-2016
Publisher
Springer Berlin Heidelberg
Published in
Langenbeck's Archives of Surgery / Issue 7/2016
Print ISSN: 1435-2443
Electronic ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-016-1426-z

Other articles of this Issue 7/2016

Langenbeck's Archives of Surgery 7/2016 Go to the issue